Artificial Intelligence (AI) in Healthcare

Artificial intelligence (AI) is steadily transforming healthcare, not through a single breakthrough but through a growing range of applications that support clinicians across diagnosis, treatment planning, workflow management, and drug development. However, the degree to which these technologies are ready for routine clinical use varies considerably between specialties. This review examines evidence from 26 peer-reviewed studies, systematic reviews, and policy papers covering ophthalmology, breast and prostate pathology, lung cancer, gastrointestinal endoscopy, gynecologic oncology, radiotherapy, chronic disease management, clinical documentation, consumer health applications, drug discovery, and the regulatory and educational frameworks surrounding AI in medicine. The strongest evidence consistently comes from imaging-based applications, where deep learning systems have achieved diagnostic performance comparable to, and in some cases exceeding, that of experienced specialists while improving efficiency and reducing workload. In contrast, AI models for treatment planning, toxicity prediction, and cancer prognosis remain promising but are often supported by retrospective, single-center studies with limited external validation. Large language models are beginning to ease the burden of clinical documentation, although concerns regarding bias, privacy, transparency, and hallucinations remain important barriers to widespread adoption. Consumer-facing AI tools and generative AI for drug discovery show considerable potential but require more rigorous validation before routine implementation. Across all domains, a common theme emerges: the greatest challenges are no longer solely technical but relate to generalizability, regulatory oversight, clinician training, and responsible integration into healthcare systems. Current evidence suggests that AI is most effective as a tool that augments, rather than replaces, clinical expertise. Continued progress will depend on robust prospective validation, transparent reporting, and thoughtful collaboration between clinicians, researchers, regulators, and healthcare institutions.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-17
DOI
https://doi.org/10.7759/cureus.119829
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Artificial Intelligence (AI) in Healthcare

Himanshi Khattar, Divyanshi Baijal, Piyush Kumar
1 links
Cureus
Artificial Intelligence in Healthcare and Education
article

Artificial Intelligence (AI) in Healthcare

Himanshi Khattar, Divyanshi Baijal, Piyush Kumar
article en

Abstract

Artificial intelligence (AI) is steadily transforming healthcare, not through a single breakthrough but through a growing range of applications that support clinicians across diagnosis, treatment planning, workflow management, and drug development. However, the degree to which these technologies are ready for routine clinical use varies considerably between specialties. This review examines evidence from 26 peer-reviewed studies, systematic reviews, and policy papers covering ophthalmology, breast and prostate pathology, lung cancer, gastrointestinal endoscopy, gynecologic oncology, radiotherapy, chronic disease management, clinical documentation, consumer health applications, drug discovery, and the regulatory and educational frameworks surrounding AI in medicine. The strongest evidence consistently comes from imaging-based applications, where deep learning systems have achieved diagnostic performance comparable to, and in some cases exceeding, that of experienced specialists while improving efficiency and reducing workload. In contrast, AI models for treatment planning, toxicity prediction, and cancer prognosis remain promising but are often supported by retrospective, single-center studies with limited external validation. Large language models are beginning to ease the burden of clinical documentation, although concerns regarding bias, privacy, transparency, and hallucinations remain important barriers to widespread adoption. Consumer-facing AI tools and generative AI for drug discovery show considerable potential but require more rigorous validation before routine implementation. Across all domains, a common theme emerges: the greatest challenges are no longer solely technical but relate to generalizability, regulatory oversight, clinician training, and responsible integration into healthcare systems. Current evidence suggests that AI is most effective as a tool that augments, rather than replaces, clinical expertise. Continued progress will depend on robust prospective validation, transparent reporting, and thoughtful collaboration between clinicians, researchers, regulators, and healthcare institutions.

Cureus
Institute of Medical Sciences (IN)
Good health and well-being
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon